News

High-Yield and Tax-Advantaged Income Funds From NEOS (April Update)

1 Mins read

This article was written by

David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As an investor entrepreneur, David invests in stocks, bonds, options, ETFs, REITs, real estate, closed end funds and alternative investment funds such as hedge funds and private credit. With over 30 years’ experience in investing, David holds a Master of Science (MS) Degree in Finance, with a concentration in Investment Analysis, from Boston University, a Certificate in Financial Planning, and a Master’s in Business Administration (MBA) from Fordham University.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SPYI, QQQI, IWMI, BTCI, MLPI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

The Buckle, Inc. (BKE) Period Ending/ Trading Statement Call Prepared Remarks Transcript

1 Mins read
Adam AkersonVP of Finance, Controller & Assistant Treasurer This is Adam Akerson with Buckle, and this is a recording of Buckle’s commentary…
News

Ultragenyx Pharmaceutical: The Market Is Overlooking 2026 Catalysts (NASDAQ:RARE)

1 Mins read
This article was written by Follow Biologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies…
News

AVIV: Should Keep Rising If The Ceasefire Holds (NYSEARCA:AVIV)

1 Mins read
This article was written by Follow With over three years of finance and consulting experience, Nikola is laser focused on finding value…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *